通过循环来准粉胺基蛋白 - - 一个药物化学的视角
Muhammad Kazim Zargaham1, Ahsan Ibrahim2, Madiha Ahmed1
1Department of Pharmaceutical Chemistry, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad 44000, Pakistan.
Bioorganic & medicinal chemistry
|March 28, 2025
概括
循环 (CPs) 在阿尔茨海默病 (AD) 研究中表现有前途. 这些分子可以设计以准粉样蛋白聚合或用于AD疫苗,提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 涉及粉样β (Aβ) 斑块,神经纤维状结 (NFT),神经炎症和神经递质缺乏.
- 循环 (CPs) 是生物活性分子,具有调节蛋白质结构和功能的潜力.
研究的目的:
- 审查循环 (CPs) 在阿尔茨海默氏症 (AD) 研究中的应用.
- 探索CP作为针对粉样蛋白聚合和AD疫苗接种的新型小分子的支架.
- 讨论CP设计的其他AD相关目标.
主要方法:
- 在阿尔茨海默氏症的循环应用的文献综述.
- 分析CP机制干扰amyloidogenic蛋白和信号传导.
- 确定基于CP的干预措施的潜在治疗目标.
主要成果:
- 慢性病理学家可以通过模仿或改变氨基原蛋白结构来干扰AD病理学.
- 对于参与AD的受体,CP可以与粉样蛋白竞争.
- 基因组作为发展小分子抗粉样蛋白聚合和AD疫苗的支架.
结论:
- 循环为开发针对阿尔茨海默病的新型治疗策略提供了一个多功能平台.
- 准粉样蛋白聚合和开发AD疫苗是CP的关键应用.
- 对各种AD病理生理路径的CP设计进行进一步的研究是有必要的.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


